health · HHS-NIH11
Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional)
National Institutes of Health · PAR-27-053
Deadline
June 16, 2028
GRANTQUICK SUMMARYPlain-English Overview
Exploratory Clinical Neuroscience Research on Substance Use Disorders. National Institutes of Health. This Notice of Funding Opportunity (NOFO) uses a R61/R33 Phased Innovation Award mechanism to support clinical research applications that are exploratory and developmental in nature and focus on understanding the neurobiological mechanisms underlying SUD, including fundamental brain function... ~6 awards expected.
Who Should Apply
State governments, Public And Indian Housing Authorities, Other Native American Tribal Organizations, Small businesses, City/township governments (+10 more)
Who Should NOT Apply
Organizations not matching the eligible applicant types listed above
Key Requirements (Plain English)
- •Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U
💡 GrantQuick Tip
Focus your proposal on clear outcomes, alignment with agency priorities, and demonstrate organizational capacity.
Competitiveness: High — limited number of awards
What This Grant Funds
Attachments
Who Can Apply
Eligible Applicant Types
Funding Details
- Cost Sharing Required?
- No
- Funding Instrument
- grant
Key Dates
Agency Contact
Division of Neuroscience and Behavior (DNB) NIDA_DNB_BCNB_r61@nih.gov
NIDA_DNB_BCNB_r61@nih.govReady to apply?
View the full NOFO and submit your application on Grants.gov